GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (WBO:SHL) » Definitions » Peter Lynch Fair Value

Siemens Healthineers AG (WBO:SHL) Peter Lynch Fair Value : €9.72 (As of Apr. 15, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Siemens Healthineers AG's PEG is 1. Siemens Healthineers AG's 5-Year TTM EBITDA Growth Rate is 5.49. Siemens Healthineers AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was €1.77. Therefore, the Peter Lynch Fair Value for today is €9.72.

As of today (2025-04-15), Siemens Healthineers AG's share price is €44.29. Siemens Healthineers AG's Peter Lynch fair value is €9.72. Therefore, Siemens Healthineers AG's Price to Peter Lynch Fair Value Ratio for today is 4.56.


The historical rank and industry rank for Siemens Healthineers AG's Peter Lynch Fair Value or its related term are showing as below:

WBO:SHL' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 3.61   Med: 5.57   Max: 7.41
Current: 4.56


During the past 10 years, the highest Price to Peter Lynch Fair Value Ratio of Siemens Healthineers AG was 7.41. The lowest was 3.61. And the median was 5.57.


WBO:SHL's Price-to-Peter-Lynch-Fair-Value is ranked worse than
87.85% of 181 companies
in the Medical Devices & Instruments industry
Industry Median: 1.71 vs WBO:SHL: 4.56

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Siemens Healthineers AG Peter Lynch Fair Value Historical Data

The historical data trend for Siemens Healthineers AG's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Peter Lynch Fair Value Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.57 7.75 9.18

Siemens Healthineers AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.12 - - 9.18 9.71

Competitive Comparison of Siemens Healthineers AG's Peter Lynch Fair Value

For the Medical Devices subindustry, Siemens Healthineers AG's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Price-to-Peter-Lynch-Fair-Value falls into.


;
;

Siemens Healthineers AG Peter Lynch Fair Value Calculation

Siemens Healthineers AG's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 5.49 *1.77
=9.72

Siemens Healthineers AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.77.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Siemens Healthineers AG  (WBO:SHL) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 5.49 instead of 15 in this case.

Siemens Healthineers AG's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=44.29/9.72
=4.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siemens Healthineers AG Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG Business Description

Address
Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines